C07C69/734

Method for producing biolubricant from vegetable oil, and biolubricant

The present invention describes a process for obtaining a biolubricant from vegetable oil, which comprises the steps of (a) esterification reaction of the product of vegetable oil hydrolysis using a branched aliphatic alcohol; (b) epoxidation reaction of the esters obtained in step (a); and (c) nucleophilic substitution reaction of the epoxidated esters obtained in step (b) using a branched aliphatic alcohol. The present invention also describes a biolubricant obtained from the process. More specifically, a biolubricant is described that is produced from a ricinoleic fatty acid, whose formula is illustrated in FIG. 1 of the present invention, and where R.sub.1 is a hydroxyl or it is from the formula R.sub.3COO.sup.−, with R.sub.3 being an alkyl radical C.sub.1-C.sub.3, preferably a methyl radical; and R.sub.2 consists of a straight chain of hydrocarbons C.sub.4-C.sub.8 and a branched chain of hydrocarbons C.sub.1-C.sub.3.

CANNABINOID DERIVATIVES AND PRECURSORS, AND ASYMMETRIC SYNTHESIS FOR SAME

The present disclosure relates to new cannabinoid derivatives and precursors and catalytic asymmetric processes for their preparation. The disclosure also relates to pharmaceutical compositions and pharmaceutical and analytical uses of the new cannabinoid derivatives. For instance, the disclosure relates to the preparation of new precursors, and the use of such precursor compounds for the preparation of isotope labelled cannabinoid products using chiral and achiral catalysts and catalytic processes. The deuterium, carbon-13 and carbon-14 containing compounds can be prepared and purified prior to transformation to the desired individual deuterated cannabinoid products.

CANNABINOID DERIVATIVES AND PRECURSORS, AND ASYMMETRIC SYNTHESIS FOR SAME

The present disclosure relates to new cannabinoid derivatives and precursors and catalytic asymmetric processes for their preparation. The disclosure also relates to pharmaceutical compositions and pharmaceutical and analytical uses of the new cannabinoid derivatives. For instance, the disclosure relates to the preparation of new precursors, and the use of such precursor compounds for the preparation of isotope labelled cannabinoid products using chiral and achiral catalysts and catalytic processes. The deuterium, carbon-13 and carbon-14 containing compounds can be prepared and purified prior to transformation to the desired individual deuterated cannabinoid products.

USE OF SUBSTITUTED CINNAMIC ACID ESTERS AS STABILISERS FOR ORGANIC MATERIALS, STABILISED ORGANIC MATERIAL, METHOD FOR STABILISING ORGANIC MATERIALS AND SPECIFIC CINNAMIC ACID ESTERS

The present invention relates to the use of specific cinnamic acid esters as stabilizers of organic materials, in particular against oxidative, thermal and/or actinic degradation. The invention also relates to a corresponding stabilized organic material. The invention further relates to a method for stabilizing organic materials, in which specific cinnamic acid esters are incorporated into the organic material. According to the invention, specific new cinnamic acid esters are also disclosed.

USE OF SUBSTITUTED CINNAMIC ACID ESTERS AS STABILISERS FOR ORGANIC MATERIALS, STABILISED ORGANIC MATERIAL, METHOD FOR STABILISING ORGANIC MATERIALS AND SPECIFIC CINNAMIC ACID ESTERS

The present invention relates to the use of specific cinnamic acid esters as stabilizers of organic materials, in particular against oxidative, thermal and/or actinic degradation. The invention also relates to a corresponding stabilized organic material. The invention further relates to a method for stabilizing organic materials, in which specific cinnamic acid esters are incorporated into the organic material. According to the invention, specific new cinnamic acid esters are also disclosed.

METHOD FOR PRODUCING AZOLE DERIVATIVE, BROMOHYDRIN DERIVATIVE AND METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING 1-CHLORO-3-(4-CHLOROPHENOXY)BENZENE

A novel method of producing an azole derivative represented by General Formula (I) includes: reacting an organometallic reagent formed from 1-bromo-2-chloro-4-(4-chlorophenoxy)benzene by transmetalation reaction with a bromopyruvic acid derivative to obtain a bromohydrin derivative; and reacting the bromohydrin derivative with imidazole, 1,2,4-triazole, or an alkali metal salt thereof to obtain the azole derivative.

METHOD FOR PRODUCING AZOLE DERIVATIVE, BROMOHYDRIN DERIVATIVE AND METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING 1-CHLORO-3-(4-CHLOROPHENOXY)BENZENE

A novel method of producing an azole derivative represented by General Formula (I) includes: reacting an organometallic reagent formed from 1-bromo-2-chloro-4-(4-chlorophenoxy)benzene by transmetalation reaction with a bromopyruvic acid derivative to obtain a bromohydrin derivative; and reacting the bromohydrin derivative with imidazole, 1,2,4-triazole, or an alkali metal salt thereof to obtain the azole derivative.

Polymeric biomaterials derived from phenolic monomers and their medical uses

Disclosed are new classes of diphenol compounds, derived from tyrosol or tyrosol analogues, which are useful as monomers for preparation of biocompatible polymers. Also disclosed are biocompatible polymers prepared from these monomeric diphenol compounds, including novel biodegradable and/or bioresorbable polymers of formula ##STR00001## These biocompatible polymers or polymer compositions with enhanced bioresorbabilty and processibility are useful in a variety of medical applications, such as in medical devices and controlled-release therapeutic compositions. The invention also provides methods for preparing these monomeric diphenol compounds and biocompatible polymers.

Polymeric biomaterials derived from phenolic monomers and their medical uses

Disclosed are new classes of diphenol compounds, derived from tyrosol or tyrosol analogues, which are useful as monomers for preparation of biocompatible polymers. Also disclosed are biocompatible polymers prepared from these monomeric diphenol compounds, including novel biodegradable and/or bioresorbable polymers of formula ##STR00001## These biocompatible polymers or polymer compositions with enhanced bioresorbabilty and processibility are useful in a variety of medical applications, such as in medical devices and controlled-release therapeutic compositions. The invention also provides methods for preparing these monomeric diphenol compounds and biocompatible polymers.

COMPOUNDS REDUCING MALODOUR PERCEPTION AND THE USE THEREOF

The present invention relates to new malodour-counteracting agents of formula (I) or stereoisomers thereof, particularly useful in blocking the olfactory perception of androstenone, Formula (I), wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7 and X have the same meaning as that defined in the claims. The present invention also relates to consumer products comprising said agents. The present invention also relates to the use of said agents to suppress or attenuate undesirable odour, as well as to methods to suppress or attenuate undesirable odour employing said compounds.

##STR00001##